Loading…
LAGAP MIGRAINE RELIEF is a brand name for Cyclizine. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: For relief of migraine pain and alleviation of associated nausea and headache.
Verbatim from this product's MHRA label. Tap a section to expand.
Tablets must be dissolved in water prior to oral administration.
Adverse effects of aspirin treatment which have been reported include:
Blood and lymphatic system disorders: Increased risk of bleeding (due to effect on platelet aggregation): haemorrhagic anaemia, iron deficiency anaemia with the respective laboratory and clinical signs and symptoms. In the case of G6PD deficiency: haemolysis, haemolytic anaemia.
Immune system disorders:
Hypersensitivity, drug hypersensitivity, allergic oedema and angioedema, anaphylactic reaction, anaphylactic shock with respective laboratory and clinical manifestations Nervous system disorders: Cerebral and intracranial haemorrhage.
Dizziness Ear and labyrinth disorders:
Hearing disturbances (such as tinnitus), Cardiac disorders In the context of severe allergic reactions: cardio-respiratory distress Vascular disorders Haemorrhage, operative haemorrhage, haematoma, muscle haemorrhage Respiratory, thoracic and mediastinal disorders Epistaxis, analgesic asthma syndrome, rhinitis, nasal congestion, bronchospasm Gastrointestinal disorders: Gastric irritation and inflammation, dyspepsia, gastrointestinal pain, abdominal pain, gingival bleeding, nausea, vomiting, gastrointestinal erosions, ulcerations, gastritis.
In some cases of intensive use may induce gastrointestinal haemorrhage, occasionally major, which may manifest as melaena or haematemesis.
Hepatobiliary disorders:
Liver disorder, transaminases increased Skin and subcutaneous tissue disorders: Hypersensitivity reactions including skin rashes, urticarial, pruritus, severe skin reactions.
Renal and urinary disorders:
If symptoms persist consult your doctor. Keep out of the reach of children. There is a possible association between aspirin and Reye's Syndrome when administered to children with a fever. Reye’s syndrome is a very rare disease which affects the brain and liver, and can be fatal.
For this reason aspirin should not be given to children under 12 years and should be avoided up to and including 15 years of age if feverish.
3 Contraindi cations As with other aspirin containing products, Femigraine is contraindicated in patients with active peptic ulceration or a history of peptic ulceration, haemophilia, or who are hypersensitive to aspirin. Adults Two tablets at onset of, or first sign of symptoms.
Two further tablets may be taken after four hours if required. Maximum in 24 hours, 8 tablets.
Elderly persons:
As adults.
Children:
Do not give to children under 12 years, and avoid up to and including 15 years of age if feverish.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Cyclizine in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
Impaired renal function Adverse effects of cyclizine treatment which have been reported include: Blood and lymphatic system disorders: Agranulocytosis Cardiac disorders: Tachycardia Eye disorders: Blurred vision, oculogyric crisis Gastrointestinal disorders: Dry mouth, dry nose, dry throat, constipation General disorders and administration site conditions: Asthenia Hepatobiliary disorders: Hepatic dysfunction, hypersensitivity hepatitis, cholestatic jaundice, cholestatic hepatitis Immune system disorders: Hypersensitivity reactions including anaphylaxis Musculoskeletal and connectivbe tissue disorders: Twitching, muscle spasms Nervous system disorders: Somnolence, headache, dystonia, dyskinesia, extrapyramidal motor disturbances, tremor, convulsions, dizziness, decreased consciousness, transient speech disorders, paraesthesia, generalised chorea Psychiatric disorders: Disorientation, restlessness, nervousness, insomnia, auditory and visual hallucinations Renal and urinary disorders: Urinary retention Respiratory, thoracis and mediastinal disorders: Bronchospasm, apnoea Skin and subcutaneous tissue disorders: Urticaria, drug rash, angioedema, allergic skin reactions, fixed drug eruption Vascular disorders: Hypertension Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard.